Biotechnology Value Fund

What is Biotechnology Value Fund?

Biotechnology Value Fund, LP, established in 1993 and based in San Francisco, is an investment fund specializing in the biotechnology sector. They strive to identify undervalued investment opportunities within this industry, utilizing a combination of rigorous financial analysis, thorough scientific evaluation, and active management to guide their investment decisions. The fund seeks to capitalize on a broad range of biotechnological advancements, ranging from new drug discoveries and innovative therapies to cutting-edge medical technologies that hold potential for significant returns.

By investing in companies at various stages of development—from early-stage ventures that possess transformative potential to mature enterprises that exhibit sustainable growth prospects—Biotechnology Value Fund, LP aims to create a diversified portfolio that balances risk and reward.

With a minimum investment threshold of $16,500,440 and a maximum investment limit of $107,000,000, they are positioned to engage in substantial equity commitments, actively supporting the growth of their portfolio companies. As active investors, they often take on influential roles in shaping the strategic direction of the entities in which they invest.

The fund operates with an investment thesis that leverages extensive industry knowledge and networks to uncover value that may be overlooked by the broader market, thereby driving superior investment performance over the long term.